{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:48:14Z","timestamp":1774993694810,"version":"3.50.1"},"reference-count":60,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1972,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Administration of<jats:italic>d,l<\/jats:italic>\u2010fenfluramine (FEN), or the more active isomer<jats:italic>d<\/jats:italic>\u2010fenfluramine (dFEN), causes long\u2010term depletion of forebrain serotonin (5\u2010HT) in animals. The mechanism underlying FEN\u2010induced 5\u2010HT depletion is not known, but appears to involve 5\u2010HT transporters (SERTs) in the brain. Some investigators have postulated that 5\u2010HT release evoked by FEN is responsible for the deleterious effects of the drug. In the present work, we sought to examine the relationship between drug\u2010induced 5\u2010HT release and long\u2010term 5\u2010HT depletion. The acute 5\u2010HT\u2010releasing effects of dFEN and the non\u2010amphetamine 5\u2010HT agonist 1\u2010(<jats:italic>m<\/jats:italic>\u2010chlorophenyl)piperazine (mCPP) were evaluated using<jats:italic>in vivo<\/jats:italic>microdialysis in rat nucleus accumbens. The ability of dFEN and mCPP to interact with SERTs was assessed using<jats:italic>in vitro<\/jats:italic>assays for [<jats:sup>3<\/jats:sup>H]\u2010transmitter uptake and release in rat forebrain synaptosomes. Drugs were subsequently tested for potential long\u2010lasting effects on brain tissue 5\u2010HT after repeated dosing (2.7 or 8.1 mg\/kg, ip \u00d7 4). dFEN and mCPP were essentially equipotent in their ability to stimulate acute 5\u2010HT release<jats:italic>in vivo<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>. Both drugs produced very selective effects on 5\u2010HT with minimal effects on dopamine. Interestingly, when dFEN or mCPP was administered repeatedly, only dFEN caused long\u2010term 5\u2010HT depletion in the forebrain at 2 weeks later. These data suggest that acute 5\u2010HT release per se does not mediate the long\u2010term 5\u2010HT depletion associated with dFEN. We hypothesize that dFEN and other amphetamine\u2010type releasers gain entrance into 5\u2010HT neurons via interaction with SERTs. Once internalized in nerve terminals, drugs accumulate to high concentrations, causing damage to cells. The relevance of this hypothesis for explaining clinical side effects of FEN and dFEN, such as cardiac valvulopathy and primary pulmonary hypertension, warrants further study.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb05194.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T17:57:26Z","timestamp":1279648646000},"page":"172-186","source":"Crossref","is-referenced-by-count":19,"title":["Serotonin Transporters, Serotonin Release, and the Mechanism of Fenfluramine Neurotoxicity"],"prefix":"10.1111","volume":"914","author":[{"given":"MICHAEL H.","family":"BAUMANN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIO A.","family":"AYESTAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHRISTINA M.","family":"DERSCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN S.","family":"PARTILLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICHARD B.","family":"ROTHMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.1997.03550080076043","article-title":"Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine","volume":"278","author":"McCann U.D.","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3565(25)30027-3","article-title":"Long\u2010term effects of p\u2010chloroamphetamine and related drugs on the central serotonergic mechanisms","volume":"192","author":"Sanders\u2010Bush E.","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_6_2","first-page":"217","article-title":"Fenfluramine: evidence for a neurotoxic action on midbrain and long\u2010term depletion of serotonin","volume":"1","author":"Harvey J.A.","year":"1975","journal-title":"Psychopharmacol. Commun."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91467-4"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890060105"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0022-3565(25)12428-2","article-title":"Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity, and time course data","volume":"253","author":"Zaczek R.","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92301-H"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-3565(25)38720-3","article-title":"Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated","volume":"269","author":"McCann U.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(86)90011-0"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.51.591.35"},{"key":"e_1_2_5_14_2","first-page":"27","article-title":"The mechanism of action of fenfluramine","volume":"51","author":"Garattini S.","year":"1975","journal-title":"Postgrad. Med. J. [Suppl. 1]"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(89)90285-6"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91189-X"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02247485"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90023-W"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)13357-9","article-title":"Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters","volume":"44","author":"Schuldiner S.","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701325"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","unstructured":"Rudnick G. 1997. Mechanisms of biogenic amine transporters.InNeurotransmitter Transporters: Structure Function and Regulation. M.E.A. Reith Ed.: 73\u2010100. Humana Press. Totowa NJ.","DOI":"10.1007\/978-1-59259-470-2_3"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb31526.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(79)90088-1"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91249-E"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90591-9"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00164a037"},{"key":"e_1_2_5_27_2","unstructured":"Nichols D.E. 1994. Medicinal chemistry and structure\u2010activity relationships.InAmphetamine and Its Analogs: Psychopharmacology Toxicology and Abuse. A.K. Cho & D.S. Segal Eds.: 1\u201041. Academic Press. New York."},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)94090-K"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90659-E"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90424-6"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-0186(91)90117-V"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(93)90034-Z"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00070-0"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-3565(25)24002-2","article-title":"GBR12909 attenuates cocaine\u2010induced activation of mesolimbic dopamine neurons in the rat","volume":"271","author":"Baumann M.H.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890140106"},{"key":"e_1_2_5_37_2","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1523\/JNEUROSCI.18-21-09069.1998","article-title":"Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats","volume":"18","author":"Baumann M.H.","year":"1998","journal-title":"J. Neurosci."},{"key":"e_1_2_5_38_2","first-page":"296","article-title":"Studies of the biogenic amine transporters","volume":"270","author":"Rothman R.B.","year":"1994","journal-title":"IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI\u201055. J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243050-00007"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90184-N"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245142"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90089-5"},{"key":"e_1_2_5_43_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)37090-9","article-title":"In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor","volume":"283","author":"Gundlah C.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90054-F"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00557-1"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68051929.x"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199511000-00013"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.8.869"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90217-5"},{"key":"e_1_2_5_50_2","first-page":"675","article-title":"Interaction of arylpiperazines with 5\u2010HT1A, 5\u2010HT1B, 5\u2010HT1C, and 5\u2010HT1D receptors: do discriminatory 5\u2010HT1B receptor ligands exist? Naunyn\u2010Schmiedeberg's Arch","volume":"339","author":"Schoeffter P.","year":"1989","journal-title":"Pharmacol."},{"key":"e_1_2_5_51_2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3565(25)22923-8","article-title":"Selective 5\u2010hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats","volume":"255","author":"Schmidt C.J.","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_52_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-3565(25)23084-1","article-title":"5\u2010HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4\u2010methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by l\u2010Dopa","volume":"256","author":"Schmidt C.J.","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(90)90109-L"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90303-X"},{"key":"e_1_2_5_55_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-3565(25)39117-2","article-title":"Relative efficacies of piperazines at the phosphoinositide hydrolysis\u2010linked 5\u2010HT2 and 5\u2010HT1C receptors","volume":"242","author":"Conn P.J.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_5_56_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/S0007125000291757","article-title":"Reduction of food intake by manipulation of central serotonin","volume":"155","author":"Garattini S.","year":"1989","journal-title":"Br. J. Psychiatry [Suppl. 8]"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199809140-00013"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90133-3"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(81)90198-2"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498259209046620"},{"key":"e_1_2_5_61_2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)37252-0","article-title":"Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue, and plasma of rats administered doses of d\u2010fenfluramine known to deplete 5\u2010hydroxytryptamine levels in brain","volume":"284","author":"Clausing P.","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05194.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05194.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb05194.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T04:46:00Z","timestamp":1740285960000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb05194.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb05194.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05194.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}